Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/jcm11123377
Keywords
mitral regurgitation; mitral insufficiency; transcatheter mitral valve repair; transcatheter mitral valve replacement; transcatheter technology; percutaneous; transluminal; endovascular; access; approach
Categories
Funding
- DZHK (German Center for cardiovascular research) [11/2022]
Ask authors/readers for more resources
This article introduces the newest devices for transcatheter mitral valve repair and replacement and presents clinical trial data to identify current challenges and directions for future research.
Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available